Seelos Therapeutics

(OTC) SEEL

Current PriceN/A

Market CapN/A

Since IPO (2019)-100%

5 YearN/A

1 Year-100%

1 Month-99%

Seelos Therapeutics Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$2.01M

Net Income (TTM)

$4.09M

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

SEEL News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Seelos Therapeutics

Industry

Pharmaceuticals

Sector

Health Care

Employees

CEO

Raj Mehra, PhD, MBA

Website

www.seelostherapeutics.com

Headquarters

New York City, NY 10022, US

SEEL Financials

Key Financial Metrics (TTM)

Gross Margin

-13%

Operating Margin

-18%

Net Income Margin

-17%

Return on Equity

Return on Capital

Return on Assets

-7%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/A

Shares Outstanding

N/A

Volume

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

-$27.91M

Operating Income

-$40.50M

EBITDA

-$37.75M

Operating Cash Flow

-$23.91M

Capital Expenditure

$0.00

Free Cash Flow

-$23.91M

Cash & ST Invst.

$3.00M

Total Debt

$14.23M

Seelos Therapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2024YOY CHG

Revenue

$376.00K

+11.9%

Gross Profit

-$379.00K

-217.7%

Gross Margin

-1.01%

N/A

Market Cap

N/A

Market Cap/Employee

N/A

Employees

N/A

Net Income

$1.71M

+105.8%

EBITDA

$1.75M

+105.9%

Quarterly Fundamentals

Name

Q2 2024YOY CHG

Net Cash

-$9.86M

-3.8%

Accounts Receivable

$188.00K

-56.4%

Inventory

$0.00

-100.0%

Long Term Debt

$0.00

-100.0%

Short Term Debt

$10.20M

-17.9%

Return on Assets

-6.99%

N/A

Return on Invested Capital

1.21%

N/A

Free Cash Flow

-$972.00K

+83.5%

Operating Cash Flow

-$972.00K

+83.5%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

VIRIVirios Therapeutics, Inc.

VIRIVirios Therapeutics, Inc.$0.16+12.40%

BLPHBellerophon Therapeutics, Inc.

BLPHBellerophon Therapeutics, Inc.$0.01-36.84%

TFFPTFF Pharmaceuticals, Inc.

TFFPTFF Pharmaceuticals, Inc.$0.07-60.05%

KERNAkerna Corp.

KERNAkerna Corp.$0.31+36.94%

IMTXImmatics N.V.

IMTXImmatics N.V.$11.04-4.08%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

HKITHitek Global

HKITHitek Global$5.90+3.04%

BBAIBigBear.ai

BBAIBigBear.ai$5.36+0.06%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$14.77-0.07%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$37.38-0.02%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$86.15+0.02%

MARAMara Holdings

MARAMara Holdings$14.98+0.04%

POETPoet Technologies

POETPoet Technologies$13.67+0.11%

Questions About SEEL

What is the current price of Seelos Therapeutics?

Seelos Therapeutics is trading at N/A per share.

What is the 52-week range for Seelos Therapeutics?

Over the past 52 weeks, Seelos Therapeutics has traded between N/A and N/A.

How much debt does Seelos Therapeutics have?

As of the most recent reporting period, Seelos Therapeutics reported total debt of $10.16M.

How much cash does Seelos Therapeutics have on hand?

Seelos Therapeutics reported $294.00K in cash and cash equivalents in its most recent financial results.

What is Seelos Therapeutics’s dividend yield?

Seelos Therapeutics does not currently have a dividend yield.

Seelos Therapeutics

Seelos Therapeutics Financials at a Glance

SEEL News

Why Seelos Therapeutics Stock Is Jumping Today

Why Seelos Therapeutics Dived by 24% Today

Why Seelos Therapeutics Stock Is Skyrocketing Today

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Seelos Therapeutics

SEEL Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Seelos Therapeutics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About SEEL

What is the current price of Seelos Therapeutics?

What is the 52-week range for Seelos Therapeutics?

How much debt does Seelos Therapeutics have?

How much cash does Seelos Therapeutics have on hand?

What is Seelos Therapeutics’s dividend yield?

Premium Investing Services